GoHealth Q1 net loss narrows to $22.5M; Adj EBITDA $28.8M, guides FY23 $750-850M revenue

GoHealth, Inc.

2023-Q1 EPS reported -$1.12 revenue$183,158,000

Net loss of $22.5M (vs. -$37.2M YoY); net revenue $183.2M (down from $270.6M).
Adjusted EBITDA $28.8M (vs. $11.1M YoY); positive TTM cash flow from ops of $26.9M.
Q1 submissions 213,645; exiting non-Encompass BPO Services, contribution $6.8M rev.
Reaffirms FY23 guidance: net rev $750-850M, Adj EBITDA $100-140M, cash flow ops $75-115M.
Reorganized to single operating segment; focus on Medicare products.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

GoHealth, Inc. reported for the three months ended March 31, 2023 results: revenue $183.2 million, net income net loss of $22.5 million. Guidance reaffirmed.

Period: for the three months ended March 31, 2023
Revenue: $183.2 million
Net income: net loss of $22.5 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

million in the prior year period. First quarter 2023 net loss of $22.5 million compared to net loss of $37.2 million in the prior year period. First quarter 2023 net revenue of $183.2 million and Adjusted EBITDA 1 of $28.8 million compared to net revenue of $270.6 million and Adjusted EBITDA 1 of $11.1 million in the prior year period. First quarter 2023 Submissions

View on SEC.gov

Browse all earnings releases →

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001808220-23-000054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.